Cryptosporidium p30, a galactose/N-acetylgalactosamine-specific lectin, mediates infection in vitro

Najma Bhat1, Angela Joe, Mercio PereiraPerrin

  • 1Division of Geographic Medicine and Infectious Diseases, Tufts-New England Medical Center, Boston, Massachusetts 02111, USA.

Insights

A newly identified protein, p30, acts as a Gal/GalNAc-specific lectin in Cryptosporidium parvum and Cryptosporidium hominis. This protein mediates parasite attachment and infection of host cells, suggesting it as a potential target for therapeutic intervention against cryptosporidiosis.

Area of Science:

  • Microbiology
  • Parasitology
  • Molecular Biology

Background:

  • Cryptosporidium species are significant global causes of diarrheal disease in humans and animals.
  • The precise molecular mechanisms of Cryptosporidium attachment to and invasion of host cells remain largely unelucidated.
  • Previous research identified Gal/GalNAc-specific lectin activity on the surface of Cryptosporidium parvum sporozoites.

Purpose of the Study:

  • To isolate and characterize a specific lectin involved in Cryptosporidium infection.
  • To investigate the role of this lectin in the attachment and invasion of host cells by Cryptosporidium parasites.
  • To explore the potential of this lectin as a therapeutic target for cryptosporidiosis.

Main Methods:

  • Isolation of a 30-kDa Gal/GalNAc-specific lectin (p30) from Cryptosporidium parvum and Cryptosporidium hominis sporozoites using Gal-affinity chromatography.
  • Gene sequencing and analysis to determine the protein's structure and predict its characteristics.
  • Expression of recombinant p30 in Escherichia coli and generation of antisera for immunological detection.
  • Localization studies of p30 within parasite stages and its association with other surface glycoproteins.
  • In vitro assays using Caco-2A cells to assess the binding and inhibitory effects of native and recombinant p30, as well as anti-p30 antisera.

Main Results:

  • A 30-kDa Gal/GalNAc-specific lectin, designated p30, was successfully isolated from C. parvum and C. hominis sporozoites.
  • The p30 gene encodes a 31.8-kDa protein with a predicted N-terminal signal sequence; gene expression occurs during intestinal epithelial cell infection.
  • p30 was found to associate with other mucin-like glycoproteins (gp900 and gp40) and is localized to the apical region of sporozoites and intracellular stages.
  • Both native and recombinant p30 demonstrated dose-dependent, saturable, and Gal-inhibitable binding to Caco-2A cells.
  • Recombinant p30 and antisera against it significantly inhibited C. parvum attachment to and infection of Caco-2A cells in vitro.

Conclusions:

  • The p30 protein plays a crucial role in mediating the attachment and infection of host intestinal epithelial cells by Cryptosporidium parvum.
  • p30's specific binding to Gal/GalNAc residues suggests a key mechanism for parasite-host cell recognition.
  • These findings highlight p30 as a potential therapeutic target for developing novel interventions against cryptosporidiosis.